807 related articles for article (PubMed ID: 22673743)
41. Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
Shin JI; Lee KH; Joo YH; Lee JM; Jeon J; Jung HJ; Shin M; Cho S; Kim TH; Park S; Jeon BY; Jeong H; Lee K; Kang K; Oh M; Lee H; Lee S; Kwon Y; Oh GH; Kronbichler A
J Autoimmun; 2019 Sep; 103():102299. PubMed ID: 31326231
[TBL] [Abstract][Full Text] [Related]
42. [Pathophysiological advances underlying the biotherapeutic revolution in inflammatory rheumatism].
Mariette X
Bull Acad Natl Med; 2012 Oct; 196(7):1261-76; discussion 1276-8. PubMed ID: 23815013
[TBL] [Abstract][Full Text] [Related]
43. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
[TBL] [Abstract][Full Text] [Related]
44. Innate immunity as the trigger of systemic autoimmune diseases.
Saferding V; Blüml S
J Autoimmun; 2020 Jun; 110():102382. PubMed ID: 31883831
[TBL] [Abstract][Full Text] [Related]
45. Infections and autoimmune diseases.
Bach JF
J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
[TBL] [Abstract][Full Text] [Related]
46. Platelets in rheumatic diseases: friend or foe?
Gasparyan AY; Ayvazyan L; Pretorius E; Kitas GD
Curr Pharm Des; 2014; 20(4):552-66. PubMed ID: 23565634
[TBL] [Abstract][Full Text] [Related]
47. Migraine in Systemic Autoimmune Diseases.
Cavestro C; Ferrero M
Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):124-134. PubMed ID: 29173190
[TBL] [Abstract][Full Text] [Related]
48. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
[TBL] [Abstract][Full Text] [Related]
49. [Role of inflammation in atherogenesis].
Rodríguez G; Mago N; Rosa F
Invest Clin; 2009 Mar; 50(1):109-29. PubMed ID: 19418732
[TBL] [Abstract][Full Text] [Related]
50. A leading role for the immune system in the pathophysiology of preeclampsia.
Laresgoiti-Servitje E
J Leukoc Biol; 2013 Aug; 94(2):247-57. PubMed ID: 23633414
[TBL] [Abstract][Full Text] [Related]
51. Vascular effects of multiwalled carbon nanotubes in dyslipidemic ApoE-/- mice and cultured endothelial cells.
Cao Y; Jacobsen NR; Danielsen PH; Lenz AG; Stoeger T; Loft S; Wallin H; Roursgaard M; Mikkelsen L; Møller P
Toxicol Sci; 2014 Mar; 138(1):104-16. PubMed ID: 24431218
[TBL] [Abstract][Full Text] [Related]
52. HIV infection and rheumatic diseases--autoimmune mechanisms in immunodeficient hosts.
Weyand CM; Goronzy JJ
Z Rheumatol; 1992; 51(2):55-64. PubMed ID: 1535472
[TBL] [Abstract][Full Text] [Related]
53. Proteome analysis of biological fluids from autoimmune-rheumatological disorders.
De Franceschi L; Bosello S; Scambi C; Biasi D; De Santis M; Caramaschi P; Peluso G; La Verde V; Bambara LM; Ferraccioli G
Proteomics Clin Appl; 2011 Feb; 5(1-2):78-89. PubMed ID: 21246742
[TBL] [Abstract][Full Text] [Related]
54. Inflammatory lipids as a target for therapy in the rheumatic diseases.
McMahon M; Brahn E
Expert Opin Investig Drugs; 2008 Aug; 17(8):1213-24. PubMed ID: 18616417
[TBL] [Abstract][Full Text] [Related]
55. The role of the endothelium in systemic vasculitis.
Savage CO; Cooke SP
J Autoimmun; 1993 Apr; 6(2):237-49. PubMed ID: 8499061
[TBL] [Abstract][Full Text] [Related]
56. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
Karsten CM; Köhl J
Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232
[TBL] [Abstract][Full Text] [Related]
57. [The association between autoimmune thyroid diseases and rheumatic diseases: a review].
MasukoHongo K; Kato T
Nihon Rinsho; 1999 Aug; 57(8):1873-7. PubMed ID: 10483268
[TBL] [Abstract][Full Text] [Related]
58. Dendritic cells as targets or therapeutics in rheumatic autoimmune disease.
Thomas R
Curr Opin Rheumatol; 2014 Mar; 26(2):211-8. PubMed ID: 24389864
[TBL] [Abstract][Full Text] [Related]
59. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
60. Chemokines in rheumatic diseases.
Szekanecz Z; Szücs G; Szántó S; Koch AE
Curr Drug Targets; 2006 Jan; 7(1):91-102. PubMed ID: 16454702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
